At the end of April the Organisation for Economic Co-operation and Development
(OECD) published an update about the activities of the ICGB. They dealt with
different contents in the field of biotechnology.
One Topic is the harmonisation of regulatory oversights in biotechnology with
the main focus on environmental risk assessment/safety of transgenomic crops.
Another is the key policy in development of biomarkers. In October 2008, an
expert workshop should discuss different issues with biomarkers, among others
about evaluation and validation in clinical use.
The results of this expert group should be published at the end of 2008.
More details about the ICGB update:
http://www.oecd.org/dataoecd/33/1/40628456.pdf
Author:
Axel H Schroeder
On behalf of the European Compliance Academy (ECA)
|